ALLISON FALIN: Open Payments
NPI 1982025763 · MARYVILLE, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$506 in 24 payments from 9 companies in 2025. Trend: 2023 $302 · 2024 $437 · 2025 $506
Food & beverage: $506
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 13 | $228 |
| Janssen Biotech, Inc. | 1 | $85 |
| Novo Nordisk Inc | 3 | $67 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $36 |
| Madrigal Pharmaceuticals | 1 | $25 |
| Aimmune Therapeutics, Inc. | 1 | $18 |
| PFIZER INC. | 1 | $17 |
| Tetraphase Pharmaceuticals, Inc. | 1 | $15 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $15 |
Products named: RINVOQ, TREMFYA, MAVYRET, Wegovy, ENTYVIO, REZDIFFRA, ZENPEP, XELJANZ.
Industry payments across TN — which companies pay providers there.
